JCCC Research Seminar featuring Dr. Zev Wainberg
Pancreatic cancer: can we make Immunotherapy work?
- Date: October 25, 2018 12:00 PM - 1:00 PM
- Location: 53-105 CHS
10833 Le Conte Ave.
Los Angeles, California 90095
Zev Wainberg, M.D. M.Sc.
Associate Professor, Department of Medicine, Hematology/Oncology, Gastrointestinal Oncology Program, UCLA/Santa Monica Cancer Center
Director, Early Phase Clinical Research Support (EPCRS)
Member, JCCC Signal Transduction and Therapeutics program
Dr. Zev Wainberg's clinical interests include designing GI (gastroenterology) cancer clinical trials. He is particularly interested in the development and testing of new targeted therapies for the treatment of colon cancer, gastric cancer and esophagus cancer. Wainberg's laboratory and translational research involves gene expression patterns in a variety of GI cancers and the molecular profiling of these cancers for novel therapies. His research also involves the targeting of GI and prostate cancers with new antibody technologies.
Light lunch served
Sponsored by the JCCC Signal Transduction and Therapeutics program.